A new medication has shown promise in treating gonorrhea, according to findings published in The New England Journal of Medicine. In clinical trials, zoliflodacin was effective in 96% of patients in treating the sexually transmitted disease with a single dose, researchers say.
New single-dose treatment for gonorrhea highly effective, study says
Sign up for Sigma Xi SmartBrief
News on scientific research and innovation
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.